CLINICAL_TRIALS
trial_result
· 2020-04-16
Clinical Trial Update: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial [Phase 2]
Summary
Phase II pilot trial evaluating TCP regimen in newly diagnosed multicentric Castleman disease; status and results not clearly posted beyond 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Multicentric Castleman Disease | Phase 2 | Status: UNKNOWN | Results posted: 2020-04-16